David Flomenbaum, MD, MS

212 posts

David Flomenbaum, MD, MS banner
David Flomenbaum, MD, MS

David Flomenbaum, MD, MS

@DFlomenbaum

Cardiology Fellow @MonteHeart | @EinsteinMed | @UChicago Biochem | Interested in humans, computers, and what they know about each other

New York, NY Katılım Ocak 2021
1.1K Takip Edilen177 Takipçiler
David Flomenbaum, MD, MS retweetledi
Ziad Obermeyer
Ziad Obermeyer@oziadias·
Interested in using LLMs to automate writing clinical notes? Remember stories like this, which happen all the time. Writing = thinking. LLMs can and do help us think, but not if they are implemented thoughtlessly.
Adam Cifu@adamcifu

Sent a patient home last week without evaluating a concern. Decided it didn't warrant evaluation. An hour later, while typing note, I had second thoughts. Called the pt and scheduled a test. Got the results today. Very glad I did the test. A close call.

English
5
16
126
19.1K
David Flomenbaum, MD, MS retweetledi
Ron Barbosa MD FACS
Ron Barbosa MD FACS@rbarbosa91·
🧵regarding the introducer sheath commonly known as a 'Cordis' catheter. We'll go over what it was originally designed for and why it ended up being adopted by other specialties for entirely different reasons. Also we'll look at its accessories and see what's inside one. (1/ )
Ron Barbosa MD FACS tweet media
English
15
177
776
207.2K
David Flomenbaum, MD, MS retweetledi
Ashwin Rajenesh MD
Ashwin Rajenesh MD@ashwinrajenesh·
"Is there a doctor on the plane?"✈️🩺 Responding to in-flight medical emergencies. #MedTwitter
Ashwin Rajenesh MD tweet mediaAshwin Rajenesh MD tweet media
English
46
1.7K
7K
841K
David Flomenbaum, MD, MS retweetledi
NEJM
NEJM@NEJM·
EPIC-SR trial: In fully vaccinated patients with risk factors for severe disease and patients (vaccinated or unvaccinated) without such risk factors, nirmatrelvir–ritonavir did not significantly shorten the time to alleviation of Covid-19 symptoms. nej.md/49kLhq3
NEJM tweet media
English
11
104
205
471.2K
David Flomenbaum, MD, MS retweetledi
Eric Topol
Eric Topol@EricTopol·
Some exciting new GLP-1 drug randomized trial evidence for *potential* disease-modifying impact on #Parkinsons disease (there are none). No progression of motor disability in the Rx group for 12 months. nejm.org/doi/full/10.10…
Eric Topol tweet media
English
1
194
775
232.5K
David Flomenbaum, MD, MS retweetledi
Eric Topol
Eric Topol@EricTopol·
The information embedded in medical scans is far beyond what we've considered. Recently, deep learning of chest X-rays provided better insight for risk of heart attack and stroke than our traditional risk score. Reviewed in the new Ground Truths (link in profile)
Eric Topol tweet media
English
10
121
476
61.1K